These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2467136)

  • 41. 24 h blood pressure control with the once daily calcium antagonist, amlodipine.
    Heber ME; Brigden G; Al-Khawaja I; Raftery EB
    Br J Clin Pharmacol; 1989 Mar; 27(3):359-65. PubMed ID: 2524208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intra-arterial monitoring of the antihypertensive effects of once-daily amlodipine.
    Broadhurst P; Heber ME; Brigden G; al-Khawaja I; Raftery EB
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S9-12. PubMed ID: 1293307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    J Hypertens; 1990 Dec; 8(12):1129-36. PubMed ID: 1962802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized prospective crossover trial of amlodipine in pediatric hypertension.
    Rogan JW; Lyszkiewicz DA; Blowey D; Khattak S; Arbus GS; Koren G
    Pediatr Nephrol; 2000 Oct; 14(12):1083-7. PubMed ID: 11045391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
    Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
    Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of the calcium antagonist amlodipine on blood pressure and platelet aggregation in hypertensive patients.
    Hernández R; Carvajal AR; Armas-de Hernández MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragán O; Machado-de Alvarado I
    Postgrad Med J; 1991; 67 Suppl 5():S38-40. PubMed ID: 1839438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A double-blind, parallel, comparative evaluation of amlodipine against captopril in the monotherapeutic treatment of mild and moderate essential hypertension: interim results.
    Velasco M; Hernández R; Urbina A; Hernández O; Guevara J
    Postgrad Med J; 1991; 67 Suppl 5():S32-4. PubMed ID: 1839436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
    Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistence of the antihypertensive efficacy of amlodipine and nifedipine GITS after two 'missed doses': a randomised, double-blind comparative trial in Asian patients.
    Ongtengco I; Morales D; Sanderson J; Lu ZR; Beilin LJ; Burke V; Puddey IB; Tanomsup S; Dayi H; Rahardjo P; Zambahari DR; Chen CY; Soenarta AA; Buranakitjaroen P; Tan C; Soon TK; Wu DJ
    J Hum Hypertens; 2002 Nov; 16(11):805-13. PubMed ID: 12444542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endurance testing for evaluation of antianginal therapy with amlodipine, a calcium channel blocking agent.
    Kinnard DR; Harris M; Hossack KF
    J Am Coll Cardiol; 1988 Sep; 12(3):791-6. PubMed ID: 2969930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amlodipine, a long-acting calcium channel blocker, attenuates morning blood pressure rise in hypertensive patients.
    Ishimitsu T; Minami J; Kawano Y; Numabe A; Takishita S; Matsuoka H
    Clin Exp Pharmacol Physiol; 1999 Jul; 26(7):500-4. PubMed ID: 10405773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.
    Kinnard DR; Harris M; Hossack KF
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S110-3. PubMed ID: 2467119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Persistence of anti-hypertensive effect after 'missed doses' of calcium antagonist with long (amlodipine) vs short (diltiazem) elimination half-life.
    Leenen FH; Fourney A; Notman G; Tanner J
    Br J Clin Pharmacol; 1996 Feb; 41(2):83-8. PubMed ID: 8838433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of amlodipine and nifedipine retard on autonomic nerve activity in hypertensive patients.
    Minami J; Ishimitsu T; Kawano Y; Matsuoka H
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):572-6. PubMed ID: 9673431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of daily anti-hypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring - utility of "hypobaric curve" and "hypobaric area".
    Kuga K; Xu DZ; Ohtsuka M; Aonuma K; Lau AH; Watanabe Y; Ohtsuka K
    Clin Exp Hypertens; 2011; 33(4):231-9. PubMed ID: 21699449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of amlodipine on blood pressure, heart rate, catecholamines, lipids and responses to adrenergic stimulus.
    Lopez LM; Thorman AD; Mehta JL
    Am J Cardiol; 1990 Nov; 66(17):1269-71. PubMed ID: 2146871
    [No Abstract]   [Full Text] [Related]  

  • 60. Amlodipine lowers blood pressure without affecting cerebral blood flow as measured by single photon emission computed tomography in elderly hypertensive subjects.
    Pandita-Gunawardena ND; Clarke SE
    Age Ageing; 1999 Sep; 28(5):451-7. PubMed ID: 10529039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.